Similarly, ApoA-I injection decreased infarct size (INF%AAR = 50.91±3.81% in ApoA-I+MI vs. 64.86±2.57% in MI alone; p<0.05), but infarct size did not significantly differ between the two treated groups (p = ns) (Figure 4B and 4C). The gene discussed is APOA1; the disease is myocardial infarction.